Drug Shortage Report for JAMP-RISPERIDONE

Last updated on 2025-08-01 History
Report ID 259883
Drug Identification Number 02359529
Brand name JAMP-RISPERIDONE
Common or Proper name Risperidone Tablets
Company Name JAMP PHARMA CORPORATION
Market Status MARKETED
Active Ingredient(s) RISPERIDONE
Strength(s) 0.25MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 500
ATC code N05AX
ATC description ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2025-06-04
Estimated end date 2025-06-30
Actual end date 2025-07-31
Shortage status Resolved
Updated date 2025-08-01
Company comments Bottle 100 is available.
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2025-08-01 English Compare
v17 2025-07-31 French Compare
v15 2025-07-31 English Compare
v16 2025-07-31 English Compare
v14 2025-07-31 English Compare
v13 2025-07-31 English Compare
v12 2025-07-31 English Compare
v11 2025-07-31 English Compare
v10 2025-07-31 English Compare
v9 2025-07-31 English Compare
v8 2025-06-25 French Compare
v7 2025-06-25 English Compare
v6 2025-06-25 French Compare
v5 2025-06-25 English Compare
v4 2025-06-16 French Compare
v3 2025-06-16 English Compare
v2 2025-06-07 French Compare
v1 2025-06-07 English Compare

Showing 1 to 18 of 18